| 0 |
CATASTROPHIC REACTION |
2 |
0.0317 |
| 1 |
THERAPEUTIC AGENT-DIAGNOSTIC TEST INTERACTION |
1 |
0.0217 |
| 2 |
ADRENERGIC SYNDROME |
1 |
0.0123 |
| 3 |
PSEUDODEMENTIA |
1 |
0.0084 |
| 4 |
PARAGANGLION NEOPLASM |
1 |
0.0068 |
| 5 |
CARCINOID CRISIS |
1 |
0.0044 |
| 6 |
VAGINAL CANCER |
1 |
0.0031 |
| 7 |
PATIENT-DEVICE INCOMPATIBILITY |
2 |
0.0029 |
| 8 |
INFUSION SITE MASS |
2 |
0.0018 |
| 9 |
TUMOUR RUPTURE |
1 |
0.0018 |
| 10 |
INFUSION SITE INDURATION |
2 |
0.0013 |
| 11 |
BRADYCARDIA FOETAL |
1 |
0.0012 |
| 12 |
BREAST ABSCESS |
1 |
0.0010 |
| 13 |
HYPOPERFUSION |
1 |
0.0010 |
| 14 |
HYPERKINESIA |
2 |
0.0009 |
| 15 |
ORCHITIS |
1 |
0.0009 |
| 16 |
RIGHT VENTRICULAR DYSFUNCTION |
1 |
0.0009 |
| 17 |
EPIDIDYMITIS |
1 |
0.0009 |
| 18 |
VASOPLEGIA SYNDROME |
1 |
0.0006 |
| 19 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 20 |
ALOPECIA AREATA |
1 |
0.0006 |
| 21 |
MICROCYTIC ANAEMIA |
1 |
0.0005 |
| 22 |
ATRIAL TACHYCARDIA |
1 |
0.0005 |
| 23 |
CALCINOSIS |
1 |
0.0004 |
| 24 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 25 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 26 |
ON AND OFF PHENOMENON |
2 |
0.0004 |
| 27 |
MICTURITION DISORDER |
1 |
0.0003 |
| 28 |
HYPOPNOEA |
1 |
0.0003 |
| 29 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 30 |
AZOTAEMIA |
1 |
0.0003 |
| 31 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 32 |
ISCHAEMIA |
1 |
0.0002 |
| 33 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 34 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 35 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 36 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 37 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 38 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 39 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 40 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 41 |
HIDRADENITIS |
1 |
0.0001 |
| 42 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 43 |
FEEDING DISORDER |
2 |
0.0001 |
| 44 |
NERVE INJURY |
1 |
0.0001 |
| 45 |
CAESAREAN SECTION |
1 |
0.0001 |
| 46 |
POLYNEUROPATHY |
1 |
0.0001 |
| 47 |
DIALYSIS |
1 |
0.0001 |
| 48 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 49 |
CYSTITIS |
2 |
0.0001 |
| 50 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 51 |
DELIRIUM |
2 |
0.0001 |
| 52 |
METASTASES TO LIVER |
1 |
0.0001 |
| 53 |
RESTLESSNESS |
2 |
0.0001 |
| 54 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 55 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 56 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 57 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 58 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 59 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 60 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 61 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 62 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 63 |
ANGINA PECTORIS |
1 |
0.0000 |
| 64 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 65 |
PREMATURE BABY |
1 |
0.0000 |
| 66 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 67 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 68 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 69 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 70 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 71 |
MOBILITY DECREASED |
2 |
0.0000 |
| 72 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 73 |
DYSURIA |
1 |
0.0000 |
| 74 |
INFLUENZA |
3 |
0.0000 |
| 75 |
HALLUCINATION |
2 |
0.0000 |
| 76 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 77 |
DISORIENTATION |
1 |
0.0000 |
| 78 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 79 |
COVID-19 |
4 |
0.0000 |
| 80 |
BRADYCARDIA |
1 |
0.0000 |
| 81 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 82 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 83 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 84 |
DEHYDRATION |
2 |
0.0000 |
| 85 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 86 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 87 |
AGITATION |
1 |
0.0000 |
| 88 |
EPISTAXIS |
1 |
0.0000 |
| 89 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 90 |
CARDIAC ARREST |
1 |
0.0000 |
| 91 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 92 |
MUSCLE SPASMS |
2 |
0.0000 |
| 93 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 94 |
HEART RATE INCREASED |
1 |
0.0000 |
| 95 |
SYNCOPE |
1 |
0.0000 |
| 96 |
FLUSHING |
1 |
0.0000 |
| 97 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 98 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 99 |
HYPERTENSION |
2 |
0.0000 |
| 100 |
CONSTIPATION |
2 |
0.0000 |
| 101 |
PALPITATIONS |
1 |
0.0000 |
| 102 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 103 |
VISION BLURRED |
1 |
0.0000 |
| 104 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 105 |
WEIGHT DECREASED |
2 |
0.0000 |
| 106 |
DRUG INTERACTION |
1 |
0.0000 |
| 107 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 108 |
PNEUMONIA |
2 |
0.0000 |
| 109 |
DIZZINESS |
3 |
0.0000 |
| 110 |
ANAEMIA |
1 |
0.0000 |
| 111 |
ALOPECIA |
1 |
0.0000 |
| 112 |
SOMNOLENCE |
1 |
0.0000 |
| 113 |
HEADACHE |
3 |
0.0000 |
| 114 |
DIARRHOEA |
3 |
0.0000 |
| 115 |
DEPRESSION |
1 |
0.0000 |
| 116 |
DECREASED APPETITE |
1 |
0.0000 |
| 117 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 118 |
INSOMNIA |
1 |
0.0000 |
| 119 |
FALL |
1 |
0.0000 |
| 120 |
FATIGUE |
2 |
0.0000 |
| 121 |
VOMITING |
1 |
0.0000 |
| 122 |
NAUSEA |
1 |
0.0000 |
| 123 |
OFF LABEL USE |
1 |
0.0000 |